Coronavirus: Emergency planning for the drug supply chain
The FDA has outlined its expectations and actions regarding supply chain and inspections in China
Breaking News
AstraZeneca joins forces with Silence to develop siRNA therapeutics
Collaboration with Silence Therapeutics has been agreed to develop small interfering RNA therapeutics that act inside ...
Sartorius supports first coronavirus vaccine in clinical trials
CanSinoBIO and the Institute of Bioengineering in China have used Sartorius’ BIOSTAT STR single-use bioreactor system ...
SPI Pharma expands patient-friendly oral dosage forms
SPI Pharma has applied its proprietary manufacturing technology to address mannitol’s inherently poor compressibility
Nitrosamines: Information for Marketing Authorisation Holders
Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...
Pharmalex summarises COVID-19 candidates in development
Researchers, companies and regulators understand that while ensuring safety, efficacy and quality are still of critical ...
e-therapeutics launches anti-viral drug discovery initiative for COVID-19
UK-based e-therapeutics discusses the moral responsibility of business and reaches out for aid with a network-driven ...
John Baker: life sciences need to address the reproducibility crisis
The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...
Evonik develops fermentation-based collagen production
Germany-based company has developed an animal-free collagen production technique
Impact BioMedical looks at compounds that block coronavirus mechanisms
The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes ...
The Lonza powder-in-capsule microdosing approach
Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...
IntelGenx: oral films are drug development’s patent trick
Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...
UK medical cannabis: quality under scrutiny
Andrew James, Marketing Director of Ellutia, explains how chromatography can uncover the potency of a batch of cannabis ...
Bora continues American expansion with GSK facility acquisition
Bora Pharmaceuticals has agreed to continue manufacturing the existing GSK product produced at the Canadian facility ...
Orion chooses Nanoform to improve bioavailability
Finnish pharmaceutical company Orion will utilise Nanoform’s proprietary CESS technology to improve the bi ...
In Brief
Most Popular in Ingredients
Featured Companies
Reports
